Cargando…

A novel signature of cuproptosis-related lncRNAs predicts prognosis in glioma: Evidence from bioinformatic analysis and experiments

Background: Glioma patients often experience unfavorable outcomes and elevated mortality rates. Our study established a prognostic signature utilizing cuproptosis-associated long non-coding RNAs (CRLs) and identified novel prognostic biomarkers and therapeutic targets for glioma. Methods: The expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Di, Xu, Yuan, Gao, Xueping, Zhu, Xuqiang, Liu, Xianzhi, Yan, Dongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123286/ https://www.ncbi.nlm.nih.gov/pubmed/37101543 http://dx.doi.org/10.3389/fphar.2023.1158723

Ejemplares similares

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
por: Xu, Qi-Tong, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer
por: Wu, Lingfeng, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer
por: Wu, Xiwen, et al.
Publicado: (2023)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
por: Zhu, Shusheng, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia
por: Zhang, Tong, et al.
Publicado: (2023)

Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
por: Liu, Li, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer
por: Wang, Qiang, et al.
Publicado: (2022)

Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer
por: Zhang, Liangping, et al.
Publicado: (2022)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
por: Chu, Binxiang, et al.
Publicado: (2022)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
por: Zhu, Yuezhi, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
por: Shi, Yinli, et al.
Publicado: (2023)

Regulatory Mechanisms of lncRNAs and Their Target Gene Signaling Pathways in Laryngeal Squamous Cell Carcinoma
por: Li, Wei, et al.
Publicado: (2020)

A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity
por: Liu, Binfeng, et al.
Publicado: (2022)

Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
por: Yalimaimaiti, Saiyidan, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
por: Liu, Chunhua, et al.
Publicado: (2023)

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
por: Li, Mingyu, et al.
Publicado: (2023)

Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
por: Liu, Xinyu, et al.
Publicado: (2022)

A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review
por: Di, Huang, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer
por: Li, Ding, et al.
Publicado: (2022)

A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma
por: Dai, Meiyu, et al.
Publicado: (2017)

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
por: Xie, Tongjin, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
por: Zhou, Zheng, et al.
Publicado: (2023)

A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature
por: Zhang, Ning, et al.
Publicado: (2023)

The Roles and Mechanisms of lncRNAs in Liver Fibrosis
por: Wang, Zhifa, et al.
Publicado: (2021)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer
por: Zhu, Zhonglin, et al.
Publicado: (2022)

A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma
por: Li, Qixuan, et al.
Publicado: (2023)

Identification of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in alimentary tract malignancies
por: Xie, Yangyang, et al.
Publicado: (2023)

A signature of cuproptosis-related lncRNAs predicts prognosis and provides basis for future anti-tumor drug development in breast cancer
por: Yu, Hao, et al.
Publicado: (2023)

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2022)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)

Targeting lncRNAs of colorectal cancers with natural products
por: Sung, Woo Jung, et al.
Publicado: (2023)

Cuproptosis‐related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients
por: Wang, Yanling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_id20fb2674fd5j7kuu5fplr064